2014
DOI: 10.1016/j.jconrel.2013.10.017
|View full text |Cite
|
Sign up to set email alerts
|

Graphene-based nanomaterials for drug delivery and tissue engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

4
697
0
4

Year Published

2014
2014
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 1,168 publications
(724 citation statements)
references
References 161 publications
4
697
0
4
Order By: Relevance
“…Approaches include its functionalization with cationic polymer, for example PEI [24]. It is used as a non-viral gene vector as it can strongly interact with the negatively charged phosphate ions of DNA and RNA [24].…”
Section: Small Molecule Drug Deliverymentioning
confidence: 99%
See 2 more Smart Citations
“…Approaches include its functionalization with cationic polymer, for example PEI [24]. It is used as a non-viral gene vector as it can strongly interact with the negatively charged phosphate ions of DNA and RNA [24].…”
Section: Small Molecule Drug Deliverymentioning
confidence: 99%
“…It is used as a non-viral gene vector as it can strongly interact with the negatively charged phosphate ions of DNA and RNA [24]. It makes transfection easy and efficient, improves cell selectivity and reduces cell toxicity.…”
Section: Small Molecule Drug Deliverymentioning
confidence: 99%
See 1 more Smart Citation
“…[12,13] Graphene (Gr) is a relatively new material that has seen applications in many branches of materials science, from electronic and thermoregulatory devices, [14][15][16] to biomedical applications. [17,18] As a 2D carbon-atom monolayer, Gr has high mechanical strength and excellent thermal and electrical conductivity, [19,20] which makes it strong candidate for improvement of many properties of compo-site materials. Indeed, graphene has been reported to improve many physico-mechanical properties of polymer composites, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…The cationic polyethylenimine (PEI) polymer that has a strong electrostatic interaction with the negatively charged phosphate of RNA or DNA can be easily decorated onto the surface of graphene in gene therapy, which enables it to treat genetic disorders like cystic fibrosis, Parkinson's disease, and cancer whilst significantly lowering the cytotoxicity of PEI [6]. Furthermore, the ability to adsorb single-stranded DNA onto graphene sheets, the capacity to quench electron donors, and the function of transportation in living cells and in vivo systems has made graphene even more promising [21]. However, in order to apply these outstanding capabilities of graphene to the biomedical field, numerous unsolved issues such as non-homogenous size, undesirable toxicity, and uncertainty of distribution data exists and hampers the clinical application.…”
mentioning
confidence: 99%